{"id":"W4404704376","doi":"10.1016/j.lungcan.2024.108040","title":"The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in patients with metastatic non-small cell lung cancer harboring sensitizing EGFR mutations","year":2024,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"National Center for Advancing Translational Sciences; Cancer Center, University of Colorado; National Institutes of Health; National Cancer Institute; Georgia Clinical and Translational Science Alliance","keywords":"Medicine; Osimertinib; Pemetrexed; Lung cancer; Oncology; Chemotherapy; Internal medicine; Cancer research; Cancer; Epidermal growth factor receptor; Cisplatin; Erlotinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001270761,0.000258676,0.0003591548,0.000161542,0.0001385142,0.00007063542,0.0000715085,0.00004301365,0.0000453321],"category_scores_gemma":[0.00001463422,0.000149895,0.00006922791,0.0006350178,0.00006443603,0.000136182,0.00001816605,0.0002330206,9.338193e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005080671,"about_ca_system_score_gemma":0.0004287057,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006480073,"about_ca_topic_score_gemma":0.0006745646,"domain_scores_codex":[0.9984627,0.00003932388,0.0003681848,0.0003845577,0.0003747901,0.0003704207],"domain_scores_gemma":[0.9990391,0.0002393678,0.0001914635,0.0002402486,0.000199048,0.00009073704],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00242756,0.0006419562,0.8720028,0.002002732,0.002366296,0.0001212868,0.03165256,0.005643487,0.003386404,0.00004826539,0.000341217,0.07936541],"study_design_scores_gemma":[0.03392291,0.00115754,0.8430605,0.02401907,0.005971591,0.000009765603,0.00265719,0.05728466,0.0296991,0.000008873176,0.001329436,0.0008793997],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9898533,0.006516798,0.0003511497,0.000509573,0.0002569959,0.001996024,0.00004476002,0.00006739563,0.0004040324],"genre_scores_gemma":[0.9968953,0.0001891501,0.001661103,0.00006573309,0.00008916827,0.0005139984,0.00004928977,0.00007975576,0.0004565209],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07848601,"threshold_uncertainty_score":0.611254,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006994395256211003,"score_gpt":0.3123541077166042,"score_spread":0.3053597124603932,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}